Cargando…

Intravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis

Peristomal pyoderma gangrenosum (PPG) is a rare subtype of pyoderma gangrenosum that is characterized by painful, necrotic ulcerations occurring in the area surrounding an abdominal stoma. PPG is typically seen in younger patients with active inflammatory bowel disease. The etiology and pathogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Behm, Kevin, Larson, David W., Colibaseanu, Dorin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369577/
https://www.ncbi.nlm.nih.gov/pubmed/25802252
http://dx.doi.org/10.1093/jscr/rjv019
_version_ 1782362769566203904
author Behm, Kevin
Larson, David W.
Colibaseanu, Dorin
author_facet Behm, Kevin
Larson, David W.
Colibaseanu, Dorin
author_sort Behm, Kevin
collection PubMed
description Peristomal pyoderma gangrenosum (PPG) is a rare subtype of pyoderma gangrenosum that is characterized by painful, necrotic ulcerations occurring in the area surrounding an abdominal stoma. PPG is typically seen in younger patients with active inflammatory bowel disease. The etiology and pathogenesis is largely unknown and risk factors are not well defined. Therapy typically involves a combination of aggressive local wound care and systemic medications. Diagnosis and management of PPG can be difficult and data on treatment are limited. We present a case of severe postoperative peristomal recalcitrant to conventional therapy successfully treated with intravenous immune globulin.
format Online
Article
Text
id pubmed-4369577
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-43695772015-06-10 Intravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis Behm, Kevin Larson, David W. Colibaseanu, Dorin J Surg Case Rep Case Reports Peristomal pyoderma gangrenosum (PPG) is a rare subtype of pyoderma gangrenosum that is characterized by painful, necrotic ulcerations occurring in the area surrounding an abdominal stoma. PPG is typically seen in younger patients with active inflammatory bowel disease. The etiology and pathogenesis is largely unknown and risk factors are not well defined. Therapy typically involves a combination of aggressive local wound care and systemic medications. Diagnosis and management of PPG can be difficult and data on treatment are limited. We present a case of severe postoperative peristomal recalcitrant to conventional therapy successfully treated with intravenous immune globulin. Oxford University Press 2015-03-23 /pmc/articles/PMC4369577/ /pubmed/25802252 http://dx.doi.org/10.1093/jscr/rjv019 Text en Published by Oxford University Press and JSCR Publishing Ltd. All rights reserved. © The Author 2015. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Reports
Behm, Kevin
Larson, David W.
Colibaseanu, Dorin
Intravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis
title Intravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis
title_full Intravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis
title_fullStr Intravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis
title_full_unstemmed Intravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis
title_short Intravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis
title_sort intravenous immunoglobulin use in managing severe, perioperative peristomal pyoderma gangrenosum following subtotal colectomy with end ileostomy for medically refractory chronic ulcerative colitis
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369577/
https://www.ncbi.nlm.nih.gov/pubmed/25802252
http://dx.doi.org/10.1093/jscr/rjv019
work_keys_str_mv AT behmkevin intravenousimmunoglobulinuseinmanagingsevereperioperativeperistomalpyodermagangrenosumfollowingsubtotalcolectomywithendileostomyformedicallyrefractorychroniculcerativecolitis
AT larsondavidw intravenousimmunoglobulinuseinmanagingsevereperioperativeperistomalpyodermagangrenosumfollowingsubtotalcolectomywithendileostomyformedicallyrefractorychroniculcerativecolitis
AT colibaseanudorin intravenousimmunoglobulinuseinmanagingsevereperioperativeperistomalpyodermagangrenosumfollowingsubtotalcolectomywithendileostomyformedicallyrefractorychroniculcerativecolitis